NLRP3 and chronic kidney disease: As abnormal activation of the NLRP3 inflammasome leads to a broad range of inflammatory disorders, F240B has the potential to ameliorate NLRP3-associated diseases, including chronic kidney disease (34–36), inflammatory bowel disease (37) and neurodegenerative disorders (38).